---
figid: PMC6892276__gr4
figtitle: Proposed in vitro metabolic biotransformation pathway for CCT241736 in human
organisms:
- Saccharomyces cerevisiae
- Matthiola incana
- Agriosomyces longus
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Canis lupus familiaris
- Ischnura aurora
pmcid: PMC6892276
filename: gr4.jpg
figlink: /pmc/articles/PMC6892276/figure/f0020/
number: F4
caption: Proposed in vitro metabolic biotransformation pathway for CCT241736 in human.
  Bold arrows represent predominance of these metabolic pathways. Dotted arrows and
  asterisked enzymes represent postulated secondary metabolic pathways based on known
  metabolite structures and primary biotransformations.
papertitle: 'Metabolism of the dual FLT-3/Aurora kinase inhibitor CCT241736 in preclinical
  and human in vitro models: Implication for the choice of toxicology species.'
reftext: Francesca L. Wood, et al. Eur J Pharm Sci. 2019 Nov 1;139:104899.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9452913
figid_alias: PMC6892276__F4
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC6892276__F4
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6892276__gr4.html
  '@type': Dataset
  description: Proposed in vitro metabolic biotransformation pathway for CCT241736
    in human. Bold arrows represent predominance of these metabolic pathways. Dotted
    arrows and asterisked enzymes represent postulated secondary metabolic pathways
    based on known metabolite structures and primary biotransformations.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CYP2C9
  - CYP3A4
  - CYP4A11
  - CYP4A22
  - CYP4B1
  - CYP4F11
  - CYP4F12
  - CYP4F2
  - CYP4F22
  - CYP4F3
  - CYP4F8
  - CYP4V2
  - CYP4X1
  - CYP4Z1
  - SST241736
---
